Is a complete FULC research report available?

No complete published report is available for Fulcrum Therapeutics, Inc. (FULC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Fulcrum Therapeutics, Inc. (FULC)

NASDAQ: FULC · USD

$3.76

+0.06 (+1.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FULC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	250.5M
Net income (ttm)	-76.1M
EPS (ttm)	-$1.14
Shares out	66.6M
Volume	829,966
Beta	3.00
Price target	$5.83	+55.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -76.1M
EPS (ttm): -$1.14
Market cap: 250.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All FULC indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001680581
Company name	Fulcrum Therapeutics, Inc.
Country	United States
Country code	US
Cusip	359616109
Employees	55
Employees Change	10%
Employees Change Percent	22.22
Enterprise value	$-77.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-07-18
Isin	US3596161097
Last refreshed	2026-07-24
Market cap	$250.5M
Market cap category	Micro-Cap
Price	$3.76
Price currency	USD
Sector	Healthcare
Sector PE	44.59
Sector PE Fwd	23.48
Sic	2834
Symbol	FULC
Website	https://www.fulcrumtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-30.46%
FCF yield	-25.56%
P/B ratio	0.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-56.8M
Net Income	$-76.1M
Net Income Growth Years	0%
Profit Per Employee	$-1.4M
ROA	-18.36
Roa5y	-21.68
ROCE	-25.69
ROE	-27.1
Roe5y	-36.09
ROIC	-18.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-46.69%
Cagr3y	-0.79%
Cagr5y	-14.93%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$346.8M
Cash	$333.3M
Current Assets	$338.7M
Current Liabilities	$9.9M
Debt	$5.9M
Debt Equity	$0.02
Equity	$333.3M
Liabilities	$13.5M
Long Term Assets	$8.1M
Long Term Liabilities	$3.6M
Net Cash	$327.4M
Net Cash By Market Cap	$131
Net Cash Growth	49.86%
Net Debt Equity	$-0.98
Tangible Book Value	$333.3M
Tangible Book Value Per Share	$5
WACC	20.26

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	34.33
Net Working Capital	$-2.1M
Quick ratio	33.97
Working Capital	$328.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.54%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-46.67%
200-day SMA	8.12
3Y total return	-2.34%
50-day SMA	4.46
50-day SMA vs 200-day SMA	50under200
5Y total return	-55.45%
All Time High	33.1
All Time High Change	-88.64%
All Time High Date	2021-09-21
All Time Low	2.25
All Time Low Change	67.11%
All Time Low Date	2023-04-12
ATR	0.23
Beta	3
Beta1y	1.05
Beta2y	1.22
Ch YTD	-66.76
High	3.78
High52	15.74
High52 Date	2025-12-08
High52ch	-76.11%
Low	3.63
Low52	2.83
Low52 Date	2026-06-02
Low52ch	32.86%
Ma50ch	-15.64%
Premarket Change Percent	-0.54
Premarket Price	$3.68
Premarket Volume	411
Price vs 200-day SMA	-53.71%
RSI	45.98
RSI Monthly	40.55
RSI Weekly	33.14
Sharpe ratio	-0.13x
Sortino ratio	-0.13
Total Return	-7.54%
Tr YTD	-66.76
Tr1m	-0.27%
Tr1w	7.43%
Tr3m	-51.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	6
Analyst Price Target Top	$7.6
Analyst Ratings	Hold
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.22
Operating Income	$-86.6M
Price target	$5.83
Price Target Change	$55.05
Price Target Change Top	$102

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	41,986,512%
Float Percent	63.01%
Shares Insiders	1.17%
Shares Institutions	92.46%
Shares Out	66,633,321
Shares Qo Q	15.86%
Shares Yo Y	7.54%
Short Float	15.3%
Short Ratio	1.21
Short Shares	9.64

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-77M
Average Volume	1,954,787.2x
Bv Per Share	5
CAPEX	$-322,000
Ch1m	-0.27
Ch1w	7.43
Ch1y	-46.67
Ch3m	-51.48
Ch3y	-2.34
Ch5y	-55.45
Ch6m	-65.97
Change	1.62%
Change From Open	3.3
Close	3.7
Days Gap	-1.62
Depreciation Amortization	1,375,000
Dollar Volume	3,120,672.2
Earnings Date	2026-07-27
Earnings Time	bmo
EBIT	$-86.6M
EBITDA	$-85.2M
EPS	$-1.14
F Score	2
FCF	$-63.9M
FCF EV Yield	82.35x
FCF Per Share	$-0.96
Financing CF	168,355,000
Fiscal Year End	December
Founded	2,015
Investing CF	-96,714,000
Ipr	-76.56
Iprfo	-74.14
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-24
Ma150	7.56
Ma150ch	-50.23%
Ma20	3.66
Ma20ch	2.73%
Net CF	8,083,000
Next Earnings Date	2026-08-04
Open	3.64
Optionable	Yes
Position In Range	87.1
Ppne	6,354,000
Pre Close	3.7
Price Date	2026-07-23
Ptbv Ratio	0.75
Relative Volume	0.42x
Share Based Comp	13,161,000
Tr6m	-65.97%
Us State	Massachusetts
Volume	829,966

Fulcrum Therapeutics, Inc. (FULC)

Coverage state: Market snapshot only — no published research

Generate the first FULC analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · FULC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FULC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FULC

Frequently asked questions